• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023

    7/24/23 11:00:50 AM ET
    $AA
    $ABR
    $AMLX
    $APP
    Aluminum
    Industrials
    Real Estate Investment Trusts
    Real Estate
    Get the next $AA alert in real time by email

    Upgrades

    Maxim Group upgraded the previous rating for Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) from Hold to Buy. For the first quarter, Galmed Pharmaceuticals had an EPS of $1.09, compared to year-ago quarter EPS of $3.60. The stock has a 52-week-high of $14.18 and a 52-week-low of $1.10. At the end of the last trading period, Galmed Pharmaceuticals closed at $1.15.

    For Nutrien Ltd (NYSE:NTR), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. Nutrien earned $1.11 in the first quarter, compared to $2.70 in the year-ago quarter. The stock has a 52-week-high of $102.70 and a 52-week-low of $52.23. At the end of the last trading period, Nutrien closed at $64.26.

    Raymond James upgraded the previous rating for D.R. Horton Inc (NYSE:DHI) from Market Perform to Outperform. For the third quarter, D.R. Horton had an EPS of $3.90, compared to year-ago quarter EPS of $4.67. At the moment, the stock has a 52-week-high of $132.30 and a 52-week-low of $66.05. D.R. Horton closed at $127.58 at the end of the last trading period.

    For Lam Research Corp (NASDAQ:LRCX), Stifel upgraded the previous rating of Hold to Buy. For the third quarter, Lam Research had an EPS of $6.99, compared to year-ago quarter EPS of $7.40. The current stock performance of Lam Research shows a 52-week-high of $663.83 and a 52-week-low of $299.63. Moreover, at the end of the last trading period, the closing price was at $623.63.

    According to MoffettNathanson, the prior rating for Shopify Inc (NYSE:SHOP) was changed from Market Perform to Outperform. Shopify earned $0.01 in the first quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $71.43 and a 52-week-low of $23.64. Shopify closed at $65.57 at the end of the last trading period.

    BTIG upgraded the previous rating for AppLovin Corp (NASDAQ:APP) from Neutral to Buy. For the first quarter, AppLovin had an EPS of $0.01, compared to year-ago quarter EPS of $0.31. The current stock performance of AppLovin shows a 52-week-high of $40.54 and a 52-week-low of $9.14. Moreover, at the end of the last trading period, the closing price was at $28.10.

    JP Morgan upgraded the previous rating for Claros Mortgage Trust Inc (NYSE:CMTG) from Underweight to Neutral. Claros Mortgage Trust earned $0.29 in the first quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.39 and a 52-week-low of $10.08. Claros Mortgage Trust closed at $12.27 at the end of the last trading period.

    For Netflix Inc (NASDAQ:NFLX), Baird upgraded the previous rating of Neutral to Outperform. Netflix earned $3.29 in the second quarter, compared to $3.20 in the year-ago quarter. At the moment, the stock has a 52-week-high of $485.00 and a 52-week-low of $211.52. Netflix closed at $427.50 at the end of the last trading period.

    According to Baird, the prior rating for Q2 Holdings Inc (NYSE:QTWO) was changed from Neutral to Outperform. For the first quarter, Q2 Holdings had an EPS of $0.35, compared to year-ago quarter EPS of $0.03. The current stock performance of Q2 Holdings shows a 52-week-high of $49.67 and a 52-week-low of $18.91. Moreover, at the end of the last trading period, the closing price was at $32.55.

    According to Canaccord Genuity, the prior rating for Coeur Mining Inc (NYSE:CDE) was changed from Hold to Buy. For the first quarter, Coeur Mining had an EPS of $0.11, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of $4.55 and a 52-week-low of $2.54. Coeur Mining closed at $3.07 at the end of the last trading period.

    Raymond James upgraded the previous rating for Becton, Dickinson and Co (NYSE:BDX) from Market Perform to Outperform. For the second quarter, Becton, Dickinson had an EPS of $2.86, compared to year-ago quarter EPS of $3.18. The stock has a 52-week-high of $269.00 and a 52-week-low of $217.00. At the end of the last trading period, Becton, Dickinson closed at $264.84.

    Goldman Sachs upgraded the previous rating for Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) from Neutral to Buy. Amylyx Pharma earned $0.02 in the first quarter, compared to $0.93 in the year-ago quarter. The stock has a 52-week-high of $41.93 and a 52-week-low of $15.82. At the end of the last trading period, Amylyx Pharma closed at $22.55.

    See all analyst ratings upgrades.

    Downgrades

    According to Capital One, the prior rating for Kodiak Sciences Inc (NASDAQ:KOD) was changed from Overweight to Equal-Weight. Kodiak Sciences earned $1.35 in the first quarter, compared to $1.83 in the year-ago quarter. The stock has a 52-week-high of $12.76 and a 52-week-low of $4.25. At the end of the last trading period, Kodiak Sciences closed at $7.29.

    For Alcoa Corp (NYSE:AA), Argus Research downgraded the previous rating of Buy to Hold. In the second quarter, Alcoa showed an EPS of $0.35, compared to $2.67 from the year-ago quarter. The current stock performance of Alcoa shows a 52-week-high of $58.19 and a 52-week-low of $31.14. Moreover, at the end of the last trading period, the closing price was at $33.38.

    Raymond James downgraded the previous rating for Waldencast PLC (NASDAQ:WALD) from Outperform to Market Perform.

    For Juniper Networks Inc (NYSE:JNPR), Raymond James downgraded the previous rating of Strong Buy to Outperform. For the first quarter, Juniper Networks had an EPS of $0.48, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $34.53 and a 52-week-low of $25.18. At the end of the last trading period, Juniper Networks closed at $30.01.

    According to JP Morgan, the prior rating for Zions Bancorp NA (NASDAQ:ZION) was changed from Overweight to Neutral. In the second quarter, Zions Bancorp showed an EPS of $1.11, compared to $1.29 from the year-ago quarter. The current stock performance of Zions Bancorp shows a 52-week-high of $59.74 and a 52-week-low of $18.26. Moreover, at the end of the last trading period, the closing price was at $36.11.

    Stifel downgraded the previous rating for Denbury Inc (NYSE:DEN) from Buy to Hold. Denbury earned $1.36 in the first quarter, compared to $1.69 in the year-ago quarter. The stock has a 52-week-high of $104.05 and a 52-week-low of $59.00. At the end of the last trading period, Denbury closed at $85.48.

    Citigroup downgraded the previous rating for Cintas Corp (NASDAQ:CTAS) from Buy to Neutral. For the fourth quarter, Cintas had an EPS of $3.33, compared to year-ago quarter EPS of $2.81. At the moment, the stock has a 52-week-high of $514.30 and a 52-week-low of $370.99. Cintas closed at $507.42 at the end of the last trading period.

    B of A Securities downgraded the previous rating for Equifax Inc (NYSE:EFX) from Neutral to Underperform. In the second quarter, Equifax showed an EPS of $1.71, compared to $2.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $240.35 and a 52-week-low of $146.12. Equifax closed at $212.35 at the end of the last trading period.

    For ON Semiconductor Corp (NASDAQ:ON), Rosenblatt downgraded the previous rating of Buy to Neutral. For the first quarter, ON Semiconductor had an EPS of $1.19, compared to year-ago quarter EPS of $1.22. The current stock performance of ON Semiconductor shows a 52-week-high of $105.35 and a 52-week-low of $54.93. Moreover, at the end of the last trading period, the closing price was at $98.76.

    Credit Suisse downgraded the previous rating for CommScope Holding Co Inc (NASDAQ:COMM) from Outperform to Neutral. For the first quarter, CommScope Hldg Co had an EPS of $0.35, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $13.73 and a 52-week-low of $3.97. CommScope Hldg Co closed at $4.76 at the end of the last trading period.

    According to RBC Capital, the prior rating for ZoomInfo Technologies Inc (NASDAQ:ZI) was changed from Outperform to Sector Perform. For the first quarter, ZoomInfo Technologies had an EPS of $0.24, compared to year-ago quarter EPS of $0.18. The current stock performance of ZoomInfo Technologies shows a 52-week-high of $51.85 and a 52-week-low of $20.33. Moreover, at the end of the last trading period, the closing price was at $26.68.

    According to JP Morgan, the prior rating for Arbor Realty Trust Inc (NYSE:ABR) was changed from Neutral to Underweight. In the first quarter, Arbor Realty Trust showed an EPS of $0.62, compared to $0.55 from the year-ago quarter. The current stock performance of Arbor Realty Trust shows a 52-week-high of $16.89 and a 52-week-low of $10.10. Moreover, at the end of the last trading period, the closing price was at $16.54.

    According to Truist Securities, the prior rating for Glacier Bancorp Inc (NYSE:GBCI) was changed from Buy to Hold. For the second quarter, Glacier Bancorp had an EPS of $0.50, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of $59.64 and a 52-week-low of $26.77. Glacier Bancorp closed at $32.25 at the end of the last trading period.

    For argenx SE (NASDAQ:ARGX), UBS downgraded the previous rating of Buy to Neutral. For the first quarter, argenx had an EPS of $0.52, compared to year-ago quarter EPS of $4.36. The current stock performance of argenx shows a 52-week-high of $550.76 and a 52-week-low of $333.07. Moreover, at the end of the last trading period, the closing price was at $548.43.

    According to RBC Capital, the prior rating for Twilio Inc (NYSE:TWLO) was changed from Sector Perform to Underperform. In the first quarter, Twilio showed an EPS of $0.47, compared to $0.00 from the year-ago quarter. At the moment, the stock has a 52-week-high of $98.59 and a 52-week-low of $41.00. Twilio closed at $62.26 at the end of the last trading period.

    Piper Sandler downgraded the previous rating for National Bankshares Inc (NASDAQ:NKSH) from Overweight to Neutral. National Bankshares earned $0.66 in the second quarter, compared to $0.93 in the year-ago quarter. The current stock performance of National Bankshares shows a 52-week-high of $43.78 and a 52-week-low of $26.41. Moreover, at the end of the last trading period, the closing price was at $30.50.

    According to Piper Sandler, the prior rating for American Express Co (NYSE:AXP) was changed from Neutral to Underweight. For the second quarter, American Express had an EPS of $2.89, compared to year-ago quarter EPS of $2.57. The current stock performance of American Express shows a 52-week-high of $182.15 and a 52-week-low of $130.82. Moreover, at the end of the last trading period, the closing price was at $170.22.

    Piper Sandler downgraded the previous rating for The Estee Lauder Companies Inc (NYSE:EL) from Overweight to Neutral. Estee Lauder Cos earned $0.47 in the third quarter, compared to $1.90 in the year-ago quarter. The current stock performance of Estee Lauder Cos shows a 52-week-high of $284.27 and a 52-week-low of $175.05. Moreover, at the end of the last trading period, the closing price was at $179.66.

    For Ncino Inc (NASDAQ:NCNO), Baird downgraded the previous rating of Outperform to Neutral. In the first quarter, Ncino showed an EPS of $0.07, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $39.45 and a 52-week-low of $19.58. At the end of the last trading period, Ncino closed at $30.91.

    According to Baird, the prior rating for Definitive Healthcare Corp (NASDAQ:DH) was changed from Outperform to Neutral. Definitive Healthcare earned $0.06 in the first quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Definitive Healthcare shows a 52-week-high of $30.10 and a 52-week-low of $8.71. Moreover, at the end of the last trading period, the closing price was at $11.53.

    According to UBS, the prior rating for Tesla Inc (NASDAQ:TSLA) was changed from Buy to Neutral. Tesla earned $0.91 in the second quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $314.67 and a 52-week-low of $101.81. At the end of the last trading period, Tesla closed at $260.02.

    According to Wells Fargo, the prior rating for FMC Corp (NYSE:FMC) was changed from Overweight to Equal-Weight. In the first quarter, FMC showed an EPS of $1.77, compared to $1.88 from the year-ago quarter. The current stock performance of FMC shows a 52-week-high of $134.38 and a 52-week-low of $88.77. Moreover, at the end of the last trading period, the closing price was at $95.16.

    According to Wells Fargo, the prior rating for The Interpublic Group of Companies Inc (NYSE:IPG) was changed from Overweight to Equal-Weight. Interpublic Gr of Cos earned $0.74 in the second quarter, compared to $0.63 in the year-ago quarter. At the moment, the stock has a 52-week-high of $40.95 and a 52-week-low of $25.14. Interpublic Gr of Cos closed at $32.87 at the end of the last trading period.

    For Stagwell Inc (NASDAQ:STGW), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. In the first quarter, Stagwell showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $9.23 and a 52-week-low of $5.16. At the end of the last trading period, Stagwell closed at $6.96.

    For Omnicom Group Inc (NYSE:OMC), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Omnicom Group earned $1.81 in the second quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $99.23 and a 52-week-low of $61.90. Omnicom Group closed at $83.81 at the end of the last trading period.

    According to Goldman Sachs, the prior rating for Halozyme Therapeutics Inc (NASDAQ:HALO) was changed from Buy to Neutral. In the first quarter, Halozyme Therapeutics showed an EPS of $0.47, compared to $0.47 from the year-ago quarter. The current stock performance of Halozyme Therapeutics shows a 52-week-high of $59.45 and a 52-week-low of $29.85. Moreover, at the end of the last trading period, the closing price was at $42.89.

    Exane BNP Paribas downgraded the previous rating for Summit Materials Inc (NYSE:SUM) from Outperform to Neutral. Summit Materials earned $0.26 in the first quarter, compared to $0.40 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.00 and a 52-week-low of $22.80. Summit Materials closed at $36.88 at the end of the last trading period.

    See all analyst ratings downgrades.

    Initiations

    Raymond James initiated coverage on Black Stone Minerals LP (NYSE:BSM) with an Outperform rating. The price target for Black Stone Minerals is set to $21.00. For the first quarter, Black Stone Minerals had an EPS of $0.60, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $20.22 and a 52-week-low of $13.41. Black Stone Minerals closed at $16.63 at the end of the last trading period.

    William Blair initiated coverage on Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) with an Outperform rating. The price target for Arcturus Therapeutics is set to $71.00. In the first quarter, Arcturus Therapeutics showed an EPS of $0.62, compared to $1.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.75 and a 52-week-low of $13.02. Arcturus Therapeutics closed at $33.84 at the end of the last trading period.

    With a Buy rating, CL King initiated coverage on Generac Holdings Inc (NYSE:GNRC). The price target seems to have been set at $178.00 for Generac Hldgs. In the first quarter, Generac Hldgs showed an EPS of $0.63, compared to $2.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $281.95 and a 52-week-low of $86.29. Generac Hldgs closed at $145.30 at the end of the last trading period.

    Craig-Hallum initiated coverage on GEN Restaurant Group Inc (NASDAQ:GENK) with a Buy rating. The price target for GEN Restaurant Gr is set to $30.00. The current stock performance of GEN Restaurant Gr shows a 52-week-high of $19.99 and a 52-week-low of $14.05. Moreover, at the end of the last trading period, the closing price was at $17.17.

    For Moderna Inc (NASDAQ:MRNA), William Blair initiated coverage, by setting the current rating at Market Perform. Moderna earned $0.19 in the first quarter, compared to $8.58 in the year-ago quarter. The stock has a 52-week-high of $217.20 and a 52-week-low of $115.06. At the end of the last trading period, Moderna closed at $126.43.

    Keefe, Bruyette & Woods initiated coverage on Fidelis Insurance Holdings Ltd (NYSE:FIHL) with an Outperform rating. The price target for Fidelis Insurance Hldgs is set to $17.00. The current stock performance of Fidelis Insurance Hldgs shows a 52-week-high of $14.04 and a 52-week-low of $12.60. Moreover, at the end of the last trading period, the closing price was at $13.75.

    Citigroup initiated coverage on Fidelis Insurance Holdings Ltd (NYSE:FIHL) with a Buy rating. The price target for Fidelis Insurance Hldgs is set to $18.00. The current stock performance of Fidelis Insurance Hldgs shows a 52-week-high of $14.04 and a 52-week-low of $12.60. Moreover, at the end of the last trading period, the closing price was at $13.75.

    Guggenheim initiated coverage on Nuvalent Inc (NASDAQ:NUVL) with a Buy rating. The price target for Nuvalent is set to $56.00. For the first quarter, Nuvalent had an EPS of $0.44, compared to year-ago quarter EPS of $0.36. At the moment, the stock has a 52-week-high of $46.85 and a 52-week-low of $14.08. Nuvalent closed at $44.73 at the end of the last trading period.

    With a Buy rating, Guggenheim initiated coverage on Savers Value Village Inc (NYSE:SVV). The price target seems to have been set at $28.00 for Savers Value Village. At the moment, the stock has a 52-week-high of $25.01 and a 52-week-low of $21.50. Savers Value Village closed at $24.56 at the end of the last trading period.

    With an Outperform rating, Raymond James initiated coverage on Kodiak Gas Services Inc (NYSE:KGS). The price target seems to have been set at $21.00 for Kodiak Gas Services. The current stock performance of Kodiak Gas Services shows a 52-week-high of $17.30 and a 52-week-low of $15.05. Moreover, at the end of the last trading period, the closing price was at $17.14.

    With a Buy rating, Stifel initiated coverage on Kodiak Gas Services Inc (NYSE:KGS). The price target seems to have been set at $22.00 for Kodiak Gas Services. At the moment, the stock has a 52-week-high of $17.30 and a 52-week-low of $15.05. Kodiak Gas Services closed at $17.14 at the end of the last trading period.

    With a Buy rating, Truist Securities initiated coverage on Kodiak Gas Services Inc (NYSE:KGS). The price target seems to have been set at $24.00 for Kodiak Gas Services. The stock has a 52-week-high of $17.30 and a 52-week-low of $15.05. At the end of the last trading period, Kodiak Gas Services closed at $17.14.

    Jefferies initiated coverage on Savers Value Village Inc (NYSE:SVV) with a Buy rating. The price target for Savers Value Village is set to $29.00. The current stock performance of Savers Value Village shows a 52-week-high of $25.01 and a 52-week-low of $21.50. Moreover, at the end of the last trading period, the closing price was at $24.56.

    Wolfe Research initiated coverage on Janus International Group Inc (NYSE:JBI) with an Outperform rating. The price target for Janus Intl Gr is set to $14.00. For the first quarter, Janus Intl Gr had an EPS of $0.18, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $12.24 and a 52-week-low of $7.98. Janus Intl Gr closed at $10.92 at the end of the last trading period.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Zillow Group Inc (NASDAQ:Z). The price target seems to have been set at $55.00 for Zillow Gr. In the first quarter, Zillow Gr showed an EPS of $0.35, compared to $0.49 from the year-ago quarter. The current stock performance of Zillow Gr shows a 52-week-high of $55.20 and a 52-week-low of $26.16. Moreover, at the end of the last trading period, the closing price was at $52.42.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Opendoor Technologies Inc (NASDAQ:OPEN). The price target seems to have been set at $4.25 for Opendoor Technologies. In the first quarter, Opendoor Technologies showed an EPS of $0.64, compared to $0.15 from the year-ago quarter. The current stock performance of Opendoor Technologies shows a 52-week-high of $6.38 and a 52-week-low of $0.92. Moreover, at the end of the last trading period, the closing price was at $4.12.

    With a Hold rating, Jefferies initiated coverage on Fidelis Insurance Holdings Ltd (NYSE:FIHL). The price target seems to have been set at $15.00 for Fidelis Insurance Hldgs. The stock has a 52-week-high of $14.04 and a 52-week-low of $12.60. At the end of the last trading period, Fidelis Insurance Hldgs closed at $13.75.

    Citigroup initiated coverage on QuantaSing Group Ltd (NASDAQ:QSG) with a Neutral rating. The price target for QuantaSing Group is set to $9.70.

    With an Overweight rating, JP Morgan initiated coverage on Kodiak Gas Services Inc (NYSE:KGS). The price target seems to have been set at $24.00 for Kodiak Gas Services. The current stock performance of Kodiak Gas Services shows a 52-week-high of $17.30 and a 52-week-low of $15.05. Moreover, at the end of the last trading period, the closing price was at $17.14.

    Roth MKM initiated coverage on GEN Restaurant Group Inc (NASDAQ:GENK) with a Buy rating. The price target for GEN Restaurant Gr is set to $23.00. The stock has a 52-week-high of $19.99 and a 52-week-low of $14.05. At the end of the last trading period, GEN Restaurant Gr closed at $17.17.

    With a Buy rating, UBS initiated coverage on Savers Value Village Inc (NYSE:SVV). The price target seems to have been set at $29.00 for Savers Value Village. The current stock performance of Savers Value Village shows a 52-week-high of $25.01 and a 52-week-low of $21.50. Moreover, at the end of the last trading period, the closing price was at $24.56.

    With a Buy rating, UBS initiated coverage on Fidelis Insurance Holdings Ltd (NYSE:FIHL). The price target seems to have been set at $18.00 for Fidelis Insurance Hldgs. The stock has a 52-week-high of $14.04 and a 52-week-low of $12.60. At the end of the last trading period, Fidelis Insurance Hldgs closed at $13.75.

    RBC Capital initiated coverage on Kodiak Gas Services Inc (NYSE:KGS) with an Outperform rating. The price target for Kodiak Gas Services is set to $25.00. The current stock performance of Kodiak Gas Services shows a 52-week-high of $17.30 and a 52-week-low of $15.05. Moreover, at the end of the last trading period, the closing price was at $17.14.

    Benchmark initiated coverage on GEN Restaurant Group Inc (NASDAQ:GENK) with a Buy rating. The price target for GEN Restaurant Gr is set to $25.00. At the moment, the stock has a 52-week-high of $19.99 and a 52-week-low of $14.05. GEN Restaurant Gr closed at $17.17 at the end of the last trading period.

    With a Buy rating, B of A Securities initiated coverage on Vivid Seats Inc (NASDAQ:SEAT). The price target seems to have been set at $10.00 for Vivid Seats. Vivid Seats earned $0.15 in the first quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Vivid Seats shows a 52-week-high of $9.89 and a 52-week-low of $6.29. Moreover, at the end of the last trading period, the closing price was at $8.32.

    Barclays initiated coverage on Kodiak Gas Services Inc (NYSE:KGS) with a Equal-Weight rating. The price target for Kodiak Gas Services is set to $19.00. The stock has a 52-week-high of $17.30 and a 52-week-low of $15.05. At the end of the last trading period, Kodiak Gas Services closed at $17.14.

    Barclays initiated coverage on Fidelis Insurance Holdings Ltd (NYSE:FIHL) with a Equal-Weight rating. The price target for Fidelis Insurance Hldgs is set to $15.00. At the moment, the stock has a 52-week-high of $14.04 and a 52-week-low of $12.60. Fidelis Insurance Hldgs closed at $13.75 at the end of the last trading period.

    Citigroup initiated coverage on Coherus BioSciences Inc (NASDAQ:CHRS) with a Buy rating. The price target for Coherus BioSciences is set to $12.00. For the first quarter, Coherus BioSciences had an EPS of $0.75, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $14.03 and a 52-week-low of $3.60. At the end of the last trading period, Coherus BioSciences closed at $4.29.

    Baird initiated coverage on Savers Value Village Inc (NYSE:SVV) with an Outperform rating. The price target for Savers Value Village is set to $27.00. The current stock performance of Savers Value Village shows a 52-week-high of $25.01 and a 52-week-low of $21.50. Moreover, at the end of the last trading period, the closing price was at $24.56.

    With a Buy rating, HC Wainwright & Co. initiated coverage on Halozyme Therapeutics Inc (NASDAQ:HALO). The price target seems to have been set at $61.00 for Halozyme Therapeutics. For the first quarter, Halozyme Therapeutics had an EPS of $0.47, compared to year-ago quarter EPS of $0.47. The current stock performance of Halozyme Therapeutics shows a 52-week-high of $59.45 and a 52-week-low of $29.85. Moreover, at the end of the last trading period, the closing price was at $42.89.

    With an Overweight rating, Piper Sandler initiated coverage on Savers Value Village Inc (NYSE:SVV). The price target seems to have been set at $30.00 for Savers Value Village. The stock has a 52-week-high of $25.01 and a 52-week-low of $21.50. At the end of the last trading period, Savers Value Village closed at $24.56.

    JMP Securities initiated coverage on Fidelis Insurance Holdings Ltd (NYSE:FIHL) with a Market Outperform rating. The price target for Fidelis Insurance Hldgs is set to $22.00. At the moment, the stock has a 52-week-high of $14.04 and a 52-week-low of $12.60. Fidelis Insurance Hldgs closed at $13.75 at the end of the last trading period.

    With a Buy rating, Goldman Sachs initiated coverage on Savers Value Village Inc (NYSE:SVV). The price target seems to have been set at $28.00 for Savers Value Village. The current stock performance of Savers Value Village shows a 52-week-high of $25.01 and a 52-week-low of $21.50. Moreover, at the end of the last trading period, the closing price was at $24.56.

    With a Buy rating, Goldman Sachs initiated coverage on Kodiak Gas Services Inc (NYSE:KGS). The price target seems to have been set at $25.00 for Kodiak Gas Services. The current stock performance of Kodiak Gas Services shows a 52-week-high of $17.30 and a 52-week-low of $15.05. Moreover, at the end of the last trading period, the closing price was at $17.14.

    Keybanc initiated coverage on Advanced Drainage Systems Inc (NYSE:WMS) with an Overweight rating. The price target for Advanced Drainage Systems is set to $150.00. In the fourth quarter, Advanced Drainage Systems showed an EPS of $1.06, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $153.29 and a 52-week-low of $75.02. At the end of the last trading period, Advanced Drainage Systems closed at $120.84.

    See all analyst ratings initiations.

    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ABR
    $AMLX
    $APP

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    ON Semiconductor Corporation
    $ON
    2/12/2026$75.00Equal Weight
    Barclays
    Generac Holdlings Inc.
    $GNRC
    2/12/2026$202.00Buy → Neutral
    Guggenheim
    Shopify Inc.
    $SHOP
    2/12/2026$150.00Neutral → Outperform
    Mizuho
    Shopify Inc.
    $SHOP
    2/12/2026$159.00Hold → Buy
    TD Cowen
    Generac Holdlings Inc.
    $GNRC
    2/12/2026$220.00 → $255.00Buy
    TD Cowen
    Glacier Bancorp Inc.
    $GBCI
    2/10/2026$55.00Neutral
    Janney
    Estee Lauder Companies Inc.
    $EL
    2/10/2026$106.00Buy → Hold
    HSBC Securities
    More analyst ratings

    $AA
    $ABR
    $AMLX
    $APP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Legal Officer Houston Julia A was granted 4,119 shares and covered exercise/tax liability with 2,614 shares, increasing direct ownership by 9% to 17,446 units (SEC Form 4)

    4 - EQUIFAX INC (0000033185) (Issuer)

    2/12/26 4:08:18 PM ET
    $EFX
    Finance: Consumer Services
    Finance

    EVP, Chief Product Officer Mao Cecilia was granted 1,374 shares and covered exercise/tax liability with 918 shares, increasing direct ownership by 6% to 8,223 units (SEC Form 4)

    4 - EQUIFAX INC (0000033185) (Issuer)

    2/12/26 4:08:19 PM ET
    $EFX
    Finance: Consumer Services
    Finance

    EVP, CFO & COO Gamble John W Jr was granted 10,983 shares and covered exercise/tax liability with 7,121 shares, increasing direct ownership by 6% to 63,421 units (SEC Form 4)

    4 - EQUIFAX INC (0000033185) (Issuer)

    2/12/26 4:08:15 PM ET
    $EFX
    Finance: Consumer Services
    Finance

    $AA
    $ABR
    $AMLX
    $APP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Firestone Karen bought $100,845 worth of shares (8,100 units at $12.45), increasing direct ownership by 15% to 63,100 units (SEC Form 4)

    4 - Amylyx Pharmaceuticals, Inc. (0001658551) (Issuer)

    12/23/25 8:48:33 PM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Baker Bros. Advisors Lp bought $60,000,008 worth of shares (2,608,696 units at $23.00) (SEC Form 4)

    4 - Kodiak Sciences Inc. (0001468748) (Issuer)

    12/19/25 4:06:09 PM ET
    $KOD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Green William C bought $115,456 worth of shares (12,800 units at $9.02), increasing direct ownership by 7% to 205,418 units (SEC Form 4)

    4 - ARBOR REALTY TRUST INC (0001253986) (Issuer)

    12/1/25 4:16:49 PM ET
    $ABR
    Real Estate Investment Trusts
    Real Estate

    $AA
    $ABR
    $AMLX
    $APP
    SEC Filings

    View All

    Advanced Drainage Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ADVANCED DRAINAGE SYSTEMS, INC. (0001604028) (Filer)

    2/12/26 4:13:04 PM ET
    $WMS
    Containers/Packaging
    Consumer Discretionary

    Twilio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TWILIO INC (0001447669) (Filer)

    2/12/26 4:10:16 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B5 filed by Coherus Oncology Inc.

    424B5 - Coherus Oncology, Inc. (0001512762) (Filer)

    2/12/26 4:08:22 PM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $ABR
    $AMLX
    $APP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for CIMERLI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug CIMERLI (SUPPL-5) with active ingredient RANIBIZUMAB-EQRN has changed to 'Approval' on 05/21/2024. Application Category: BLA, Application Number: 761165, Application Classification:

    5/22/24 9:41:01 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for LOQTORZI issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug LOQTORZI (SUPPL-1) with active ingredient TORIPALIMAB-TPZI has changed to 'Approval' on 04/22/2024. Application Category: BLA, Application Number: 761240, Application Classification:

    4/23/24 4:41:07 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for UDENYCA issued to COHERUS BIOSCIENCES INC

    Submission status for COHERUS BIOSCIENCES INC's drug UDENYCA (SUPPL-15) with active ingredient PEGFILGRASTIM-CBQV has changed to 'Approval' on 12/22/2023. Application Category: BLA, Application Number: 761039, Application Classification:

    12/27/23 4:38:39 AM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $ABR
    $AMLX
    $APP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Twilio Announces Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $1.37 billion, up 14% reported and 12% organic year-over-year Full Year Revenue of $5.07 billion, up 14% reported and 13% organic year-over-year Fourth Quarter and Full Year GAAP Income from Operations of $57 million and $158 million, respectively Fourth Quarter and Full Year Non-GAAP Income from Operations of $256 million and $924 million, respectively Twilio (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, reported financial results for its fourth quarter and full year ended December 31, 2025. "2025 was one of the most balanced and successful years of execution in Twilio's his

    2/12/26 4:05:00 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock

    REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. ("Coherus" or the "Company") (NASDAQ:CHRS), today announced a proposed underwritten public offering of its common stock (the "Offering"). In addition, Coherus intends to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the Offering are being offered by Coherus. Coherus intends to use the net proceeds from the proposed Offering to support the ongoing commercialization of LOQTORZI® (toripalimab-tpzi), to conti

    2/12/26 4:05:00 PM ET
    $CHRS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Advanced Drainage Systems Announces Pricing of $500 Million of 5.375% Senior Notes Due 2034

    Advanced Drainage Systems, Inc. (NYSE:WMS) ("ADS" or the "Company"), a leading provider of innovative water management solutions in the stormwater and onsite wastewater industries, today announced that it priced a private offering (the "Offering") of $500 million aggregate principal amount 5.375% senior unsecured notes due 2034 (the "Notes"). The Company's present and future direct and indirect domestic subsidiaries that guarantee its senior secured credit facility will guarantee the Notes. The Offering is expected to close on February 27, 2026, subject to customary closing conditions. In connection with the issuance of the Notes, the Company expects to amend its existing senior secured c

    2/12/26 4:03:00 PM ET
    $WMS
    Containers/Packaging
    Consumer Discretionary

    $AA
    $ABR
    $AMLX
    $APP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Barclays initiated coverage on onsemi with a new price target

    Barclays initiated coverage of onsemi with a rating of Equal Weight and set a new price target of $75.00

    2/12/26 9:42:14 AM ET
    $ON
    Semiconductors
    Technology

    Generac downgraded by Guggenheim with a new price target

    Guggenheim downgraded Generac from Buy to Neutral and set a new price target of $202.00

    2/12/26 7:22:33 AM ET
    $GNRC
    Metal Fabrications
    Consumer Discretionary

    $AA
    $ABR
    $AMLX
    $APP
    Leadership Updates

    Live Leadership Updates

    View All

    Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

    Announces appointment of Claire M. Fraser, Ph.D., to its Board of DirectorsForms a global life sciences and diagnostics leader focused on high-volume testing in regulated applicationsAnnounces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advanced Diagnostics, and Waters Materials SciencesMILFORD, Mass., Feb. 9, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company (NYSE:BDX) ("BD"). The transaction forms a global life sciences and diagnostics leader, equipped with best-in-class technologies

    2/9/26 8:40:00 AM ET
    $BDX
    $WAT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company

    Company reports 2025 fourth quarter and full year results, provides 2026 outlook  The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredientsThe FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 prioritie

    2/4/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    Lam Research Appoints Cadence CEO Anirudh Devgan to Board of Directors

    FREMONT, Calif., Feb. 3, 2026 /PRNewswire/ -- Lam Research Corp. (NASDAQ:LRCX) today announced that Dr. Anirudh Devgan has joined its board of directors. Dr. Devgan, who currently serves as president and chief executive officer (CEO) of Cadence Design Systems, Inc., brings to Lam deep semiconductor ecosystem and technology expertise. Since joining Cadence in 2012, Dr. Devgan has held senior leadership roles at the company, a market leader in computational software company, AI and digital twins. He has served as CEO and as a member of the board of directors of Cadence since 2021, and as president of the company since 2017, having previously held the positions of executive vice president and g

    2/3/26 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $AA
    $ABR
    $AMLX
    $APP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Kodiak Gas Services Inc.

    SC 13G/A - Kodiak Gas Services, Inc. (0001767042) (Subject)

    12/13/24 4:41:52 PM ET
    $KGS
    Natural Gas Distribution
    Utilities

    Amendment: SEC Form SC 13D/A filed by nCino Inc.

    SC 13D/A - nCino, Inc. (0001902733) (Subject)

    12/12/24 6:29:06 PM ET
    $NCNO
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $AA
    $ABR
    $AMLX
    $APP
    Financials

    Live finance-specific insights

    View All

    Twilio Announces Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $1.37 billion, up 14% reported and 12% organic year-over-year Full Year Revenue of $5.07 billion, up 14% reported and 13% organic year-over-year Fourth Quarter and Full Year GAAP Income from Operations of $57 million and $158 million, respectively Fourth Quarter and Full Year Non-GAAP Income from Operations of $256 million and $924 million, respectively Twilio (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, reported financial results for its fourth quarter and full year ended December 31, 2025. "2025 was one of the most balanced and successful years of execution in Twilio's his

    2/12/26 4:05:00 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Q2 Holdings, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results

    Q2 Holdings, Inc. (NYSE:QTWO), a leading provider of digital transformation solutions for financial services, today announced results for its fourth quarter and full year ending December 31, 2025. GAAP Results for the Fourth Quarter and Full-Year 2025 Revenue for the fourth quarter of $208.2 million, up 14 percent year-over-year and up 3 percent from the third quarter of 2025. Full-year 2025 revenue of $794.8 million, up 14 percent year-over-year. GAAP gross margin for the fourth quarter of 55.4 percent, up from 52.6 percent for the prior-year quarter and up from 54.0 percent for the third quarter of 2025. GAAP gross margin for full-year 2025 of 54.1 percent, up from 50.9 percent fo

    2/11/26 4:15:00 PM ET
    $QTWO
    Computer Software: Prepackaged Software
    Technology

    AppLovin Announces Fourth Quarter and Full Year 2025 Financial Results

    AppLovin Corporation (NASDAQ:APP) ("AppLovin"), a leading marketing platform, today announced financial results for the quarter and full year ended December 31, 2025 and posted a financial update on its Investor Relations website located at https://investors.applovin.com. Fourth Quarter and Full Year 2025 Financial Highlights:   Quarter Ended       Year Ended       December 31,       December 31,     (In millions, except percentages)   2025     2024   % Change     2025     2024   % Change R

    2/11/26 4:05:00 PM ET
    $APP
    Computer Software: Programming Data Processing
    Technology